Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group.
Schwartz
Robert S
RS
Minneapolis Heart Institute Foundation, Minnesota Cardiovascular Research Institute, 920 E 28th St, Minneapolis, MN 55407, USA. rss@rsschwartz.com
Edelman
Elazer R
ER
Carter
Andrew
A
Chronos
Nicolas A
NA
Rogers
Campbell
C
Robinson
Keith A
KA
Waksman
Ron
R
Machan
Lindsay
L
Weinberger
Judah
J
Wilensky
Robert L
RL
Goode
Jennifer L
JL
Hottenstein
O D
OD
Zuckerman
Bram D
BD
Virmani
Renu
R
D000818:Animals; D001344:Autopsy; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic / Q000517:prevention & control; D004343:Drug Implants; D004867:Equipment Design; D005069:Evaluation Studies as Topic; D017408:Guidelines as Topic; D006965:Hyperplasia; D023421:Models, Animal; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011817:Rabbits; D012008:Recurrence; D012107:Research Design; D016037:Single-Blind Method; D013045:Species Specificity; D013048:Specimen Handling; D015607:Stents; D034421:Sus scrofa; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology
D004343:Drug Implants; D010975:Platelet Aggregation Inhibitors